Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia.
Narrow Moat: Intangible assets, high switching costs.
Differentiation: Speed and precision in trial execution, especially for complex therapies like biologics and gene therapies.
Ranks: Strong
GreenRed: 363 / 3,147
GreenBlue: 258 / 2,500
- ClinTrak®: Integrated Clinical Trial Management System.
- Electronic Data Capture (EDC), ePRO/eCOA, eConsent: Digital tools for patient-reported outcomes and consent.
- Interactive Response Technology (IRT): Randomization and drug supply management.
- Wearables & Apps: TrialPACE (patient app), OnPACE (site app), and centralized monitoring tools.
Narrow Moat: Intangible assets, high switching costs.
Differentiation: Speed and precision in trial execution, especially for complex therapies like biologics and gene therapies.
Ranks: Strong
GreenRed: 363 / 3,147
GreenBlue: 258 / 2,500
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.